Assessment of Autogenous Dentin Graft in Treatment of Infra-bony Defect

October 6 University

Status

Completed

Conditions

Periodontitis (Stage 3)

Treatments

Procedure: Autogenous demineralized dentin nanoparticles

Study type

Interventional

Funder types

Other

Identifiers

NCT05258006

Details and patient eligibility

About

The aim of the present study was to evaluate the effect of demineralized autogenous dentine on treatment of infrabony defects.

Full description

In this study, the investigators tested the effect of demineralized autogenous dentine as a bone graft in treatment of stage III periodontitis in term of probing pocket depth reduction, mean gain in clinical attachment level, and bone gain in defect sites.

Enrollment

20 patients

Sex

All

Ages

16 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with good systemic health and no contraindication for periodontal surgery.
Patients who are able to maintain good oral hygiene.
Gingival thickness for the site selected should be ≥1mm.
Probing depth of ≥ 6mm.
Patient has at least one hopeless teeth

Exclusion criteria

Active infectious diseases (hepatitis, tubercu¬losis, HIV, etc....).
Medically compromised patients.
Smokers and alcoholic abusers
People who suffer from any systemic disease that affect the periodontium.
Pregnant, postmenopausal women.
People who take anti-inflammatory drugs, anti¬biotics or vitamins within the previous 3 month.
People who use mouth washes regularly
Participants in other clinical trials.